626 related articles for article (PubMed ID: 15695406)
1. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.
Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P
Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria as targets for cancer chemotherapy.
Gogvadze V; Orrenius S; Zhivotovsky B
Semin Cancer Biol; 2009 Feb; 19(1):57-66. PubMed ID: 19101636
[TBL] [Abstract][Full Text] [Related]
3. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D
Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria in cancer cells: what is so special about them?
Gogvadze V; Orrenius S; Zhivotovsky B
Trends Cell Biol; 2008 Apr; 18(4):165-73. PubMed ID: 18296052
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism.
Pelicano H; Xu RH; Du M; Feng L; Sasaki R; Carew JS; Hu Y; Ramdas L; Hu L; Keating MJ; Zhang W; Plunkett W; Huang P
J Cell Biol; 2006 Dec; 175(6):913-23. PubMed ID: 17158952
[TBL] [Abstract][Full Text] [Related]
8. The Warburg Effect returns to the cancer stage.
Zhivotovsky B; Orrenius S
Semin Cancer Biol; 2009 Feb; 19(1):1-3. PubMed ID: 19162190
[No Abstract] [Full Text] [Related]
9. Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells.
Kumar MA; Nair M; Hema PS; Mohan J; Santhoshkumar TR
Mol Carcinog; 2007 Mar; 46(3):231-41. PubMed ID: 17186548
[TBL] [Abstract][Full Text] [Related]
10. Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak.
Tomiyama A; Serizawa S; Tachibana K; Sakurada K; Samejima H; Kuchino Y; Kitanaka C
J Natl Cancer Inst; 2006 Oct; 98(20):1462-73. PubMed ID: 17047195
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
12. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
13. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.
Danial NN; Gramm CF; Scorrano L; Zhang CY; Krauss S; Ranger AM; Datta SR; Greenberg ME; Licklider LJ; Lowell BB; Gygi SP; Korsmeyer SJ
Nature; 2003 Aug; 424(6951):952-6. PubMed ID: 12931191
[TBL] [Abstract][Full Text] [Related]
14. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase.
Santamaría G; Martínez-Diez M; Fabregat I; Cuezva JM
Carcinogenesis; 2006 May; 27(5):925-35. PubMed ID: 16361271
[TBL] [Abstract][Full Text] [Related]
15. Targeting mitochondria for cancer therapy.
Hockenbery DM
Environ Mol Mutagen; 2010 Jun; 51(5):476-89. PubMed ID: 20213841
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.
Bodur C; Karakas B; Timucin AC; Tezil T; Basaga H
Mol Carcinog; 2016 Nov; 55(11):1584-1597. PubMed ID: 26373689
[TBL] [Abstract][Full Text] [Related]
18. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
[TBL] [Abstract][Full Text] [Related]
20. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells?
Moreno-Sánchez R; Rodríguez-Enríquez S; Saavedra E; Marín-Hernández A; Gallardo-Pérez JC
Biofactors; 2009; 35(2):209-25. PubMed ID: 19449450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
